# The Effects of Dexmedetomidine on cTnI and GP-BB in Patients Undergoing OPCABG

> **NCT03163693** · NA · UNKNOWN · sponsor: **General Hospital of Ningxia Medical University** · enrollment: 40 (actual)

## Conditions studied

- Coronary Artery Bypass, Off-Pump

## Interventions

- **DRUG:** dexmedetomidine
- **OTHER:** normal saline

## Key facts

- **NCT ID:** NCT03163693
- **Lead sponsor:** General Hospital of Ningxia Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03163693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03163693, "The Effects of Dexmedetomidine on cTnI and GP-BB in Patients Undergoing OPCABG". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03163693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*